Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.04 |
mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.097 | 0.04 |
mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.04 |
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.099 | 0.05 |
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |